Skip to content
value.today
Total raised
$12 M
3 rounds on record
Latest round
$3 M
Sep 2014
First round on record
Jan 2013
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Medbox, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2014$3 MNo. 3$2 to $10 million

Medbox, Inc.: Raise no. 3, Sep 2014

Investors in this round

1 investor had bought by the notice of Oct 6, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Medbox, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
$330,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Nevada

People named in the notice

  • Guy Marsala · Executive Officer, Director
  • Matthew Feinstein · Executive Officer, Director
  • Thomas Iwanski · Executive Officer
  • Vincent Mehdizadeh · Executive Officer
  • J. Mitchell Lowe · Director
  • Ned L. Siegel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Amount sold of $2,500,000 includes $1,000,000 which has closed and $1,500,000 which the investor has contractually committed to purchase.”

Signed by Guy Marsala, Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 6, 2014. Read the notice at the SEC.

debt, optionsSEC
Jul 2014$9 MNo. 2$2 to $10 million

Medbox, Inc.: Raise no. 2, Jul 2014

Investors in this round

3 investors had bought by the notice of Jun 30, 2015: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Medbox, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$9 M of $9 M offered; $0 M still to sell
Smallest investment taken
$25,000
What was sold
equity, debt, securities to be acquired by exercising them, other: Offering of 10% convertible debentures, warrant and underlying common stock.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • C. Douglas Mitchell · Executive Officer
  • Guy Marsala · Executive Officer, Director
  • Jeffrey Mitchell Goh · Executive Officer
  • J. Mitchell Lowe · Director
  • Jennifer Mitchell Love · Director
  • Ned L. Siegel · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes compensation payable in ordinary course of business for services rendered as employees.”

Signed by C. Douglas Mitchell, Cfo. Source: SEC Form D and 3 amendments, newest notice filed Jun 30, 2015. Read the notice at the SEC.

equity, debtSEC
Jan 2013$1 MNo. 1Under $2 million

Medbox, Inc.: Raise no. 1, Jan 2013

Investors in this round

0 investors had bought by the notice of May 23, 2013: 0 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 2 investors are named for Medbox, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$1 M of $5 M offered; $4 M still to sell
Smallest investment taken
$10,000
What was sold
equity, debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Nevada

People named in the notice

  • Dr. Bruce Bedrick · Executive Officer, Director
  • Leila Guieb · Executive Officer
  • William Smith · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dr. Bruce Bedrick, Director. Source: SEC Form D, newest notice filed May 23, 2013. Read the notice at the SEC.

equity, debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Medbox, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2015).

    SEC Form D · Jun 2015

  • Revenue range over time, as stated in its notices: revenue between $1 million and $5 million in 2013; revenue between $5 million and $25 million in 2014.

    SEC Form D (revenue range) · Oct 2014

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Oct 2014

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

2 named in official filings. Open an investor to see everything it has backed.

Investors in Medbox, Inc.
InvestorKindAmountRoundRoleSource
Bruce BedrickPersonnot statednot statedHeld Series A preferred stock, 10% owner, director (Form 3, 2014)SEC Form 3
Vincent Chase, Inc.Companynot statednot statedHeld Series A preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 3 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Medbox, Inc.
NameRoleNamed in
C. Douglas MitchellExecutive officerJun 2015
Guy MarsalaExecutive officerJun 2015
Jeffrey Mitchell GohExecutive officerJun 2015
Matthew FeinsteinExecutive officerOct 2014
Thomas IwanskiExecutive officerOct 2014
Vincent MehdizadehExecutive officerOct 2014
Matthew L. FeinsteinExecutive officerJul 2014
Dr. Bruce BedrickExecutive officerMay 2013
Leila GuiebExecutive officerMay 2013
Guy MarsalaDirectorJun 2015
J. Mitchell LoweDirectorJun 2015
Jennifer Mitchell LoveDirectorJun 2015
Ned L. SiegelDirectorJun 2015
Matthew FeinsteinDirectorOct 2014
Mitchell J. LoweDirectorOct 2014
Bruce BedrickDirectorJul 2014
Matthew L. FeinsteinDirectorJul 2014
Dr. Bruce BedrickDirectorMay 2013
William SmithDirectorMay 2013